The development of rapid, highly sensitive detection methods for neuron-specific enolase (NSE) and S100-b protein is very important as the levels of NSE and S100-b protein in the blood are closely related to brain injury. Therefore, we can use NSE and S100-b protein concentration detection to realize the preliminary judgment of brain injury. In this paper, we report that a simple label-free three dimensional hierarchical plasmonic nano-architecture has been designed for the sensitive surface-enhanced Raman scattering immunosensor detection of NSE and S100-b. Owing to the active group of the hollow gold nanospheres (HAuNPs), the redox molecules 4-mercaptobenzoic acid (4-MBA) and Nile blue A (NBA) absorb antibodies and provide signal generation. The prepared HAuNPs@4-MBA and HAuNPs@NBA are used as probes to easily construct a surface-enhanced Raman scattering immunosensor. When protein biomarkers are present, the sandwich nanoparticles are captured over the substrate, forming a confined plasmonic field, leading to an enhanced electromagnetic field in intensity and in space. As a result, the Raman reporter molecules are exposed to a high density of "hot spots", which remarkably amplify the Raman signal, improving the sensitivity of the surface-enhanced Raman scattering immunosensor. Under the optimized conditions, the linear range of the proposed immunosensor is from 0.2 to 22 ng mL À1 for both NSE and S100-b. The lowest detectable concentration is 0.1 and 0.06 ng mL À1 for NSE and S100-b, respectively. The assay results for serum samples with the proposed method were in a good agreement with the standard enzyme-linked immunosorbent assay method. The proposed immunosensor is promising in clinical diagnosis. This method, which utilizes the surface-enhanced Raman scattering of HAuNPs, has great potential in the detection of biomarkers, which are vital in medical diagnoses and disease monitoring.
Introduction
Traumatic brain injury (TBI) is a leading cause of death and disability in the developed world.
1 Approximately 2.8 million TBI-related emergency department (ED) visits, hospitalizations and deaths have occurred. 2 The current ED standard of care for the initial assessment of a patient's potential TBI includes employment of the Glasgow Coma Scale (GCS), in which a clinician numerically assesses the brain impairment based on the bedside physical examination, and computed tomography (CT) scans. 3, 4 These screening tools are presently used for initial clinical management and prognosis of TBI. However, they cannot provide information on pathophysiological processes, and they are not very sensitive or specic, particularly in the case of mild or moderate TBI. 5 On the other hand, some ED patients with traumatic injuries and a poor GCS score are subject to brain impairment due to intoxication from alcohol and/or drugs instead of from a true brain injury. Although early CT scans are useful for detection of intracerebral hemorrhage, they are oen less effective at early detection of the more common cerebral contusions and diffuse axonal injury. Additionally, there is growing concern regarding radiation exposure from the use of screening CT scans in patients with possible TBI. 6, 7 Magnetic resonance imaging (MRI) is much more sensitive for early detection of TBI and does not expose patients to radiation. However, these studies are expensive and timeconsuming, oen require patient sedation, and are frequently unavailable in the ED. Early and accurate diagnosis of TBI is clinically important, as currently routine yet potentially unnecessary screening imaging might be avoided. Additionally, many patients with even mild TBI may experience short-or long-term sequelae, including changes in attention and memory and emotional disturbances, which may benet from early diagnosis and intervention. [8] [9] [10] Importantly, TBI clinical trials, such as those testing potential early therapies aimed at, for example, decreasing secondary injury, have been severely hampered by the dilemma of early diagnosis of true TBI as opposed to intoxication, with this "noise" requiring an increase in sample size and expense, and possible dilution of the measurable effects of the potential therapy. Measurement of protein biomarkers can provide an alternative route for rapid and accurate disease diagnosis. Protein biomarkers are present in human uids, such as blood, saliva, or urine, which makes the tests much less invasive, rapid, and inexpensive and avoids the radiation involved with CT scans as well as the time, sedation, and expense of MRIs.
11-15
The most common TBI biomarkers are glial brillary acidic protein (GFAP), S100-b, and neuron-specic enolase (NSE), which are released into circulation aer brain damage occurs. Several methods have been employed to measure the protein biomarkers, including enzyme-linked immunosorbent assay (ELISA), western blot, and agarose gel electrophoresis.
16-18
However, those methods generally involve time-consuming operation processes and large sample volumes, and require expensive instruments, which cannot be used as point-of-care (POC) analytical tools for rapid and low-cost clinical diagnosis.
19,20
Surface-enhanced Raman scattering has become a powerful and sensitive analytical technique for chemical and biomedical analysis; compared with traditional immunoassays, surfaceenhanced Raman scattering has some especial advantages.
21-24
Firstly, surface-enhanced Raman scattering has better antiinterference resistance to other molecules in complex sample systems owing to its ngerprint characteristic. 25, 26 Second, surface-enhanced Raman scattering can highly enhance the Raman signals with good stability, convenience and reproducibility. [27] [28] [29] [30] As a result, surface-enhanced Raman scattering has been widely used in the detection of proteins for immunoassays.
31-34
In this paper, a surface-enhanced Raman scattering immunoassay system with high sensitivity and effectivity is constructed for the detection of NSE and S100-b, which involves the combination of hollow gold nanospheres (HAuNPs) surfaceenhanced Raman scattering probes and HAuNPs immunoassay substrates instead of using silver nanomaterial. Considering the easy oxidation of silver nanomaterial, gold nanomaterial is more stable, which is more suitable for biological monitoring. [35] [36] [37] This study is quite new in terms of synthesis of HAuNPs and conguration of a surface-enhanced Raman scattering immunotest for the simultaneous detection of biomarkers. During the process of surface-enhanced Raman scattering, the antigen molecules connect with HAuNPs surfaceenhanced Raman scattering probes and HAuNPs immunoassay substrates through the specic immune recognition between antigen and antibody. As the Raman reporter and linking group, the Raman signal of 4-mercaptobenzoic acid (4-MBA) and Nile blue A (NBA) are amplied early and also inuenced by the concentration of antigen molecules. The result exhibits a broad linear range (0.2 to 22 ng mL À1 ) with correlation coef- 
Experimental

Materials
Silica colloids suspension, g-amino-propyl-triethoxysilane, 1-[3-(dimethylamino)propyl]-3-carbodiimide hydrochloride and Nhydroxysuccinimide were purchased from Sigma. Dimercaptosuccinic acid and bovine serum albumin were purchased from Aladdin Ltd. (Shanghai, China). Chloroauric acid tetrahydrate, hydrogen peroxide (30%), 4-mercaptobenzoic acid and Nile blue A were purchased from Shanghai Chemical Reagent Co., Ltd., China. Neuron-specic enolase and S100-b and anti-NSE antibodies I and II and anti-S100-b antibodies I and II were purchased from Linc-Bio Science Co. (Shanghai, China). All other chemical reagents were of analytical grade or higher and were used without further purication. Aqueous solutions were prepared using Milli-Q water from a Milli-Q system (resistivity $ 18 MU). All chemicals were used as received without further purication.
Ethics statement
All experiments were performed in compliance with the National Health and Family Planning Commission of the People's Republic of China, and approved by the ethics committee at Taishan Medical University. Informed consents were obtained from the human participants of this study.
Synthesis of hollow gold nanospheres
The gold-silica with a silica core was synthesized as previously reported. Briey, silica (0.013 g mL À1 ) was rstly dispersed in 40 mL of ethanol and amino-functionalized by g-amino-propyltriethoxysilane (1% v/v in ethanol) at 80 C. $2 nm gold nanoparticles were synthesized by etrakis hydroxymethyl phosphonium chloride reducing chloroauric acid. Functionalized silica was added to the gold nanoparticles under stirring to form the gold-silica composite. The growing solution was prepared by mixing 750 mL of deionized water, 200 mg of potassium carbonate, and 12 mL of 1% chloroauric acid and then stirring for 30 min. The gold-silica composite and hydrogen peroxide were added in turn to the growing solution while stirring. The gold-silica was concentrated by centrifugation at 3000 rpm for 20 min and redispersed in 10 mL of water for further use. For corroding the silica core, 3 mL of freshly prepared HF aqueous solution (0.02 M) was added to etch the 7 mL of goldsilica suspension (OD 700 nm ¼ 1.0) at room temperature for 10 min with gentle stirring, the silica colloidal spheres completely dissolved and a hollow interior appeared to form hollow gold-silica. Their diameters were calculated from 100 particles from SEM images.
Preparation of hollow gold nanosphere immunoassay substrate
The fabrication of APTES-functionalized indium tin oxide conductive glass was carried out according to the literature procedures in our previous paper and the literature reported by Enders et al. 38, 39 All indium tin oxide conductive glass slips were washed with aqua regia and ultrapure water at least ve times. The slips were further cleaned in ethanol with sonication three times and dried at 70 C for 2 h in an air oven. The cleaned indium tin oxide conductive glass slips were vertically immersed in a 1% (v/v) ethanol solution of g-amino-propyltriethoxysilane in anhydrous ethanol at 70 C for 2 h, three times in ethanol with sonication to remove excess silane, and dried for 2 h at 100 C in an air oven.
Then, the functional indium tin oxide conductive glass slide was separated lengthways into two cross-links of the two portions. For the fabrication of the immunosensor, slips were vertically dipped overnight into the colloidal suspension of HAuNPs under gentle stirring to obtain the HAuNPs layers. Finally, the substrate was washed with ultrapure water three times and dried for 30 min at 30 C. Thus, a suitable gold-silica substrate was obtained. For surface functionalization, the obtained HAuNPs substrate was incubated in an sodium hydroxide solution (4 mM) containing 2 mM dimercaptosuccinic acid for 4 h and then washed with phosphate-buffered saline to remove free dimercaptosuccinic acid. The carboxy groups in the dimercaptosuccinic acid-modied substrate were activated by immersion in a solution containing 150 mM ethylene dichloride and 30 mM N-hydroxysuccinimide for 30 min with phosphatebuffered saline. Subsequently, the substrate was incubated in NSE and S100-b coating antibody molecules for 4 h and then washed with phosphate-buffered saline to remove free antibody molecules. Finally, in order to avoid nonspecic binding during the immunoassay, the substrate was immersed into bovine serum albumin solution (1% in phosphate-buffered saline) to block the residual vacant portion and then washed with phosphate-buffered saline.
SERS immunoassay for NSE and S100-b antigen detection
Briey, the as-prepared nanoparticles were washed twice with distilled water. 100 mL of as-prepared HAuNPs was dispersed in 400 mL of distilled water. 50 mL of dimercaptosuccinic acid (10 À6 mol L À1 ) was added aer stirring for 30 minutes and washed twice, then co-incubated with 60 mL of NBA aqueous solution (10 À5 mol L À1 ) for 30 minutes. The NBA-adsorbed
HAuNPs were re-dispersed in 500 mL of phosphate-buffered saline (pH ¼ 7.4), and subsequently co-incubated with 20 mL of NSE labeling antibody (10 mg mL À1 ) for 1 hour. Finally, HAuNPs@NBA@NSE labelled antibody nanoparticles were sealed with bovine serum albumin (1 wt%) to cover up the antibody positive sites. Secondly, we prepared HAuNPs@4-MBA@S100-b labeling antibody nanoparticles. Briey, the as-prepared nanoparticles were washed with distilled water twice. 100 mL of as-prepared nanoparticles was dispersed in 400 mL of distilled water, then co-incubated with 50 mL of 4-MBA aqueous solution (10 À6 mol L À1 ) for 30 minutes. The 4-MBA-adsorbed HAuNPs were re-dispersed in 500 mL of phosphate-buffered saline (pH ¼ 7.4) and subsequently co-incubated with 20 mL of S100-b labeling antibody (10 mg mL
À1
) for 1 hour. Finally, HAuNPs@4-MBA@S100-b labelled antibody nanoparticles were sealed with bovine serum albumin (1 wt%) to cover up the antibody positive sites.
The HAuNPs substrate was mixed with 1 mL of two kinds of labeling antibody (10 mg mL À1 ) for 1 h. Finally, it was sealed with bovine serum albumin (1 wt%) to cover up the antibody positive sites. Equivalent labeling probes and coating substrates were merged together forming a 1 mL mixture solution. Then different amounts of S100-b and NSE antigens were added. Aer co-incubating for 2 h and washing with phosphate-buffered saline, these samples were dried at room temperature for subsequent Raman signal obtaining.
Characterization
Scanning electron microscopy measurements were made using an Xl30 Esem Feg scanning electron microscope at an accelerating potential of 20 kV. Fourier transform infrared spectroscopy measurements were made on a Fourier transform infrared spectroscopy spectrometer tensor 27 (Bruker Optik GmbH, Ettlingen, Germany). The Raman experiments were collected using a Renishaw Invia Reex system equipped with Peltier-cooled charge-coupled device detectors and a Leica microscope. Raman measurements were performed with an excitation line provided by a He-Ne laser (785 nm wavelength) via a 50Â long working distance objective lens, of which the NA is 0.50. In each sample, ve random spots were selected to detect their Raman signals. The nal signal was obtained from the average signal of these random spots.
Results and discussion
Synthesis and characterization of hollow gold nanospheres Fig. 1A shows a typical scanning electron microscope image of the prepared product. It can be seen that the as-prepared HAuNPs have regular spherical morphology and uniform size distribution. This image demonstrates that the diameter of gold-silica is 170 nm, with $110 nm for the HAuNPs. Fig. 1B shows that the successful fabrication of HAuNPs can be directly demonstrated by energy-dispersive X-ray (EDX) spectroscopy. The result indicates that only element Au is present in the HAuNPs. It conrms that the silica core had disappeared and HAuNPs were formed. Fig. 1C shows the ultraviolet-visible absorption spectra of AuNPs (black) and HAuNPs (red) in water, which have a peak at about 700 nm. Fig. 1D shows the absorbance spectra of AuNPs (black) and HAuNPs (red). Here, their plasmon absorbance intensity was nearly unchanged. On the other hand, the maximum absorption wavelength of HAuNPs had a slight blue shi compared to that of AuNPs, which may be caused by the change of the refractive index. By changing the wall thickness of the AuNPs, the maximum absorption wavelength of HAuNPs can be adjusted to obtain the maximum resonance with an excitation light source. As mentioned in previous reports, HAuNPs show strong enhancement effects from individual particles because hot spots can be localized on the pinholes in the HAuNPs structures. Fig. 1D shows SERS spectra for 4-MBA-labeled AuNPs and HAuNPs. The results show that the Raman intensity of 4-MBA-labeled HAuNPs at 1080 cm À1 is 10 times higher than that of AuNPs, indicating the excellent SERS enhancement effect of HAuNPs. Characterization of hollow gold nanosphere substrates Fig. 4A shows that the HAuNPs are distributed fairly uniformly on the indium tin oxide conductive glass surface. To better characterize the uniformity of the surface-enhanced Raman scattering signal, a Raman mapping experiment was carried out aer the surface had been coated with NBA. Fig. 4B shows the surface-enhanced Raman scattering mapping of the HAuNPs substrate, using the largest NBA band at 592 cm À1 as the mapping signal. The scan area was 25 Â 30 mm 2 , the step size was 1.4 mm, the laser power was 2 mW, and the acquisition time at each point was 10 s. The deviation of surface-enhanced Raman scattering intensities from the strongest point to the weakest point is less than 6%, indicating that the HAuNPs substrate has a very uniform surface-enhanced Raman scattering enhancement effect over the whole surface.
Characterization of hollow gold nanosphere tags
The above analysis indicates that the obtained HAuNPs substrate has good uniformity and reproducibility, which is the premise for immunoassays based on surface-enhanced Raman scattering of HAuNPs. To further conrm the successful conjugation of the HAuNPs substrate, the Fourier transform infrared spectra of the dimercaptosuccinic acid-labeled HAuNPs substrate and the HAuNPs immunoassay substrate (HAuNPs substrate@NBA@S100-b@NSE antibody) were measured. Fig. 5A and B show the Fourier transform infrared spectra. The 1700 cm À1 peak in the Fourier transform infrared spectra is attributed to the C]N stretching vibration in carboxy groups of NBA. The 1710 cm À1 peak in the Fourier transform infrared spectrum of the dimercaptosuccinic acid-labeled HAuNPs substrate is assigned to the C]O stretching vibration in carboxy groups of dimercaptosuccinic acid. The 1650 cm À1 and 1551 cm À1 peaks in the Fourier transform infrared spectrum of the HAuNPs immunoassay substrate are due to C]O symmetric and asymmetric stretching modes in amido bonds, which are present in the S100-b and NSE coating antibody molecules and also formed by the chemical combination of carboxy groups in the S100-b and NSE antibody molecules with carboxy groups in dimercaptosuccinic acid. Based on the above results, dimercaptosuccinic acid and S100-b and NSE coating antibody molecules are successfully conjugated to the surface of the HAuNPs substrate. Under the action of specic binding, combining can overcome the effects of the steric problems.
SERS spectra analysis and immunoassay detection
Under optimal conditions, the performance of the multiplexed immunoassay was evaluated with S100-b and NSE. Fig. 6 shows that the surface-enhanced Raman scattering immunoassay decreased as the concentrations of S100-b and NSE increased. Based on the specic combination of antigen and antibody, HAuNPs surface-enhanced Raman scattering tags can conjugate with HAuNPs immunoassay substrates. The Raman signals of 4-MBA and NBA are the same as the amount of the connected antibody, which is equal to the concentration of antigen molecules. Therefore, the surface-enhanced Raman scattering intensity of the reporter molecules can be indirectly identied as the antigen concentration. During the process of the immunoassays, the S100-b and NSE molecules were applied with different concentrations (0.2 to 22 ng mL À1 ). Under light . From the results, we can learn that the surface-enhanced Raman scattering immunoassay for S100-b antigen based on HAuNPs is sensitive and effective.
SERS spectra analysis clinical application
The feasibility of the prepared immunosensor for possible clinical application is investigated by analyzing human serum samples from students of Tumour Hospital. The immunoassay for human serum samples was investigated by analyzing three real samples in comparison with enzyme-linked immunosorbent assay technique. Each human serum sample was analyzed ten times. The analytical performance of the proposed immunosensor was compared with the S100-b and NSE immunosensors reported previously. Table 1 demonstrates that there is no signication difference between the results given by the two methods. The results and the relative errors between the two methods ranged from À1.25 to 8.81% for S100-b and from À4.17 to 8.48% for NSE. As a result, the prepared immunosensor could be reasonably applied in the clinical determination of S100-b and NSE.
The selectivity of the surface-enhanced Raman scattering immunoassay is important in biological sample analysis so interference study was conducted using bovine serum albumin (2), glucose (3), carcinoembryonic antigen (4), and neuronspecic enolase (5) . The Raman signal of the surfaceenhanced Raman scattering immunoassay with 2 ng mL À1 of S100-b and NSE mixture solution and 10 ng mL À1 of the above interfering substances was respectively measured. Fig. 7 shows that the change in the Raman intensity with the interfering substances is 1.7% less than that without interferences. These observations indicate that the immunoassay exhibits acceptable selectivity for the determination of S100-b and NSE. The reproducibility and accuracy of the immunoassay were evaluated by the surface-enhanced Raman scattering. Five equal indium tin oxide conductive glass substrates were prepared for the detection of 10 ng mL À1 S100-b and NSE. The relative standard deviation of the measurements for the ve electrodes is 4.9% and 6.3%. The results indicate that the accuracy and reproducibility of the fabricated immunosensor are acceptable. The stability of the sensors was evaluated over a period of 10 days of storage (at 4 C). Aer 2 days and 10 days, the surfaceenhanced Raman scattering signal of the immunosensor decreases to approximately 92% and 83% of its initial value, respectively. Regeneration plays a key role in the application and development of immunosensors. Aer the immunosensor is used to detect S100-b and NSE, the immunosensor is treated with 1 M urea solution for 5 min to break the antibody-antigen Fig. 7 Raman intensity of the SERS immunoassay with 2 ng mL À1 S100-b and NSE mixture solution + 10 ng mL À1 serum albumin (2), glucose (3), carcinoembryonic antigen (4) and neuron-specific enolase (5).
linkage. The indium tin oxide conductive substrate is resused for ve consecutive measurements of one sample aer the immunosensor is regenerated and a relative standard deviation of 6.7% was obtained at an S100-b concentration of 10 ng mL À1 .
The results indicate that the immunosensor can be regenerated and used again. Based on the above-mentioned observations, our proposed immunosensor could be applied for determination of S100-b and NSE in clinical diagnosis.
Conclusions
In summary, a surfactant-free and template-free method for the high-yield synthesis of HAuNPs was reported. Meanwhile, a simple label-free surface-enhanced Raman scattering multiplexed immunosensor based on HAuNPs was developed for simultaneous detection of S100-b and NSE. The proposed immunosensor shows excellent performance for S100-b and NSE detection with a remarkable detection limit, good stability, and wide linear range, and exhibits a good correlation with enzyme-linked immunosorbent assay. Such HAuNPs surfaceenhanced Raman scattering substrate may hold great promise for applications in areas including biosensing, environmental monitoring and clinical diagnostics.
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